Prosight Management’s Select Medical SEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,035,086
Closed -$15.4M 53
2025
Q4
$15.4M Buy
1,035,086
+160,171
+18% +$2.26M 3.18% 14
2025
Q3
$11.2M Buy
874,915
+521,095
+147% +$6.94M 2.62% 19
2025
Q2
$5.37M Buy
+353,820
New +$5.52M 1.31% 24
2024
Q4
Sell
-48,377
Closed -$909K 48
2024
Q3
$909K Buy
+48,377
New +$927K 0.22% 40
2022
Q2
Sell
-168,503
Closed -$2.18M 35
2022
Q1
$2.18M Buy
+168,503
New +$2.22M 1.41% 20

Other funds holding SEM

Prosight Management's SEM Position: Q1 2026 in Review

Prosight Management sold out of Select Medical (SEM) in Q1 2026, closing a stake of 1,035,086 shares — an estimated $15.4M sold.

Prosight Management first reported a position in SEM in Q1 2022 and held it in 5 quarters. The position peaked at $15.4M in Q4 2025. 278 funds tracked by Wall St. Rank hold SEM as of Q1 2026.

  • Prosight Management reported no remaining Select Medical position as of Q1 2026 after selling out during the quarter.
  • Prosight Management sold 1,035,086 Select Medical shares in Q1 2026, an estimated $15.4M.
  • Prosight Management first reported a position in Select Medical in Q1 2022 and held it in 5 quarters.
  • Prosight Management's Select Medical position peaked at $15.4M in Q4 2025.
  • 278 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.

Based on Prosight Management's 13F filing for Q1 2026, filed 15 May 2026.